# data[].attributes.body
Respiratory Syncytial Virus

# data[].attributes.attachment_link.provider_name
Centers for Disease Control and Prevention

# data[].attributes.attachment_link.readable_text
Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious. Infants and older adults are more likely to develop severe RSV and need hospitalization. If you are age 60 or older, a vaccine is available to protect you from severe RSV. Talk to your healthcare provider to see if it's right for you. If you are pregnant, you can get an RSV vaccine between 32-36 weeks of pregnancy to protect your infant after birth, or a preventive antibody can be given to your baby after birth.

Know the symptoms to look for and how to care for people with RSV.

Preventive options help protect certain groups at high risk of severe RSV.

Help protect yourself and your loved ones from RSV infection.

# data[].attributes.attachment_link.title
Learn about Respiratory Syncytial Virus Infection (RSV).

# data[].attributes.attachment_link.description
Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms but can be serious.

# data[].attributes.body
RSV is a common respiratory virus that often presents as mild, cold-like symptoms, but can be fatal in some infants and older adults, if not treated immediately. It is caused by an infection from the human orthopneumovirus. Usually, infection occurs because an infected person coughs or sneezes, and those infected droplets get onto someone else and are transported to their eyes, mouth, or nose. Touching a surface that has the virus on it and not using proper handwashing techniques after can also lead to transmission of the virus.

# data[].attributes.body
Human Orthopneumovirus

# data[].attributes.body
Decrease in appetite

Fever, coughing and sneezing

Bronchiolitis and pneumonia

# data[].attributes.body
"Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults"

The RSV prefusion F protein-based

(RSV preF) vaccine showed to be effective in adults greater than or equal to 60 years of age.

# data[].attributes.body
Edward E. Walsh, M.D.

University of Rochester Medical Center

# data[].attributes.body
RSV vaccines by GSK and Pfizer for people 60 years of age and older

Pfizer vaccine for women 32-36 weeks pregnant to protect infant

RSV preventative antibody for infants and young children

# data[].attributes.body
Rapid RSV antigen test with a nasal fluid sample

Mouth swab or blood test may also be done to look at white blood cell counts and search for viruses

# data[].attributes.body
Mild infections may go away on their own within a couple of weeks. In these cases, a fever reducer or pain reliever may be used to aid symptoms.

Possible RSV Treatments When Hospitalized include:

oxygen

IV fluids

mechanical ventilation

tube feeding

mucus suctioning